<DOC>
	<DOC>NCT01211028</DOC>
	<brief_summary>The main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with expanded adipose derived stroma/stem cells sue, administered intramuscularly in patients with critical leg ischemia.</brief_summary>
	<brief_title>Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Severe peripheral vascular disease not amenable to bypass or angioplasty Age &gt;40 years old Normal renal function (creatinine &lt; 1.6) Non pregnant female Lifespan &gt; 6 months Age &lt;40 years old Refusal to give informed consent and/orCognitively disabled Congestive heart failure or stroke in the last 3 months History of cancer or myeloproliferative disorders Proliferative retinopathy Pregnancy Positive screening test for HIV, Hepatitis B or Hepatitis C Buerger patient Cachexia or predicted impossibility for a biopsy of at least 30 grams of fat tissue Pregnancy or lactation Having been non controlled severe pathology</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Critical leg ischemia</keyword>
	<keyword>Adipose derived Stroma/Stem Cells</keyword>
	<keyword>Autologous</keyword>
	<keyword>Angiogenesis</keyword>
</DOC>